Public Impact
PROGRAMS
Public Impact
Key Goals
Development: Develop policy and regulatory recommendations that guide responsible governance of genomic technologies
Translation: Generate meaningful dialogue with diverse stakeholder communities and provide free educational resources
Deployment: Increase the global availability of affordable and accessible genomic therapies, agricultural products, and tools
Flagship Projects
Promoting Responsible Governance
The IGI is advancing science policy to ensure genome engineering developments serve the public good.
The Public Impact team engages with policymakers and regulators around the world to establish responsible governance mechanisms.
Engaging Stakeholders
We facilitate dialogue through outreach to key stakeholders to ensure that genome-editing technology is equitably developed and distributed.
We convene stakeholder communities to discuss applications, risks and benefits. We integrate stakeholder feedback into our research direction to ground our priorities in societal needs.
Improving Equitable Access
Our research creates new paradigms for equitable and affordable applications of genome-editing technologies, including investigating new models of commercialization.
Genetic therapies on the market have list prices over $3 million per dose. An IGI-led task force developed a roadmap to deliver affordable genetic therapies with a focus on the role of mission-driven institutions. We empower scientists in low- and middle-income countries to use CRISPR technology to develop products specific to their own needs.
Partnerships
The IGI maximizes its impact around the world by working in close collaboration with a network of global partners in health, climate, and agriculture.
IGI’s formal partnership with the CGIAR
African CRISPR course in partnership with the African Plant Breeding Academy
